Fluorescent in situ hybridization (FISH) is used in many medical setti
ngs to identify the genetic or chromosomal abnormality characterizing
a disease. FISH techniques may be used to classify a sample of a patie
nt's cells into genomic categories, one or more of which is associated
with the disease. The clinical goal is to determine whether there is
a positive proportion of diseased cells in the patient. or to estimate
this proportion. Unfortunately, such data are often subject to classi
fication error inherent in FISH methodology. However, when additional
data are available from cells of known type, typically from normal sub
jects, this information may be combined with the patient's data to per
form the desired inference while correcting for misclassification. We
provide a method for estimating the proportions of cells of each categ
ory and testing whether a particular proportion is positive in each of
several patients when such background data are available. Our approac
h is to model the misclassification probabilities, jointly to estimate
the model parameters and each patient's cell type proportions by usin
g maximum likelihood and to use this to obtain likelihood ratio tests
and confidence intervals. The method is applied to blood cell count da
ta from chronic myelogenous leukaemia patients. where FISH is used to
identify the chromosomal translocation characterizing the disease.